SEC Form 4 · accession 0001753939-19-000001
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Eric Teague
Officer — Chief Financial Officer
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stockF1 | $0.32 | Jan 15, 2019 | A | 100,000 | A | — | Jan 15, 2029 | common stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Options to purchase 25,000 shares of common stock are exercisable immediately, and options to purchase 25,000 shares of common stock shall vest on each of the one, two and three year anniversaries of the grant date.